- Home
- FENC vs REAX Comparison
FENC vs REAX Comparison
Compare FENC & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FENC | REAX |
|---|---|---|
| Founded | 1996 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.0M | 435.9M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FENC | REAX |
|---|---|---|
| Price | $11.85 | $2.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $14.50 | $5.49 |
| AVG Volume (30 Days) | 166.1K | ★ 5.2M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | $23.04 |
| Revenue Next Year | $41.08 | $15.98 |
| P/E Ratio | $197.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $1.55 |
| 52 Week High | $13.25 | $5.41 |
Technical Indicators
Market Signals| Indicator | FENC | REAX |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | 77.18 |
| Support Level | $9.74 | $2.38 |
| Resistance Level | N/A | $2.91 |
| Average True Range (ATR) | 0.72 | 0.16 |
| MACD | 0.13 | 0.08 |
| Stochastic Oscillator | 66.79 | 95.50 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.